Novartis Pharma K.K. Files Applicaion Seeking Additional Indication For Glivec In Japan

December 27, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Tokyo (JCN) Dec 26, 2005 - Novartis Pharma announced on December 26 that it has filed an application for an additional indication of Glivec (imatinib), its proprietary molecular-targeted agent, with the Ministry of Health, Labor and Welfare.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Asia